Liver histology during Mipomersen therapy for severe hypercholesterolemia (2014)
- Authors:
- USP affiliated author: SANTOS FILHO, RAUL DIAS DOS - FM
- School: FM
- DOI: 10.1016/j.jacl.2014.08.002
- Subjects: HIPERCOLESTEROLEMIA (TERAPIA); FÍGADO (ANATOMIA E HISTOLOGIA); FÁRMACOS (SISTEMA DIGESTÓRIO)
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Journal of Clinical Lipidology
- Volume/Número/Paginação/Ano: v. 8, n. 6, p. 606-611, 2014
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc-nd
-
ABNT
HASHEMI, Nikroo; ODZE, Robert D.; MCGOWAN, Mary P.; SANTOS, Raul D. Liver histology during Mipomersen therapy for severe hypercholesterolemia. Journal of Clinical Lipidology, New York, v. 8, n. 6, p. 606-611, 2014. Disponível em: < doi: 10.1016/j.jacl.2014.08.002 > DOI: 10.1016/j.jacl.2014.08.002. -
APA
Hashemi, N., Odze, R. D., McGowan, M. P., & Santos, R. D. (2014). Liver histology during Mipomersen therapy for severe hypercholesterolemia. Journal of Clinical Lipidology, 8( 6), 606-611. doi:10.1016/j.jacl.2014.08.002 -
NLM
Hashemi N, Odze RD, McGowan MP, Santos RD. Liver histology during Mipomersen therapy for severe hypercholesterolemia [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 6): 606-611.Available from: doi: 10.1016/j.jacl.2014.08.002 -
Vancouver
Hashemi N, Odze RD, McGowan MP, Santos RD. Liver histology during Mipomersen therapy for severe hypercholesterolemia [Internet]. Journal of Clinical Lipidology. 2014 ; 8( 6): 606-611.Available from: doi: 10.1016/j.jacl.2014.08.002 - Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients?: a post-hoc analysis
- Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)
- Prevalência de síndrome metabólica e escore de risco de Framingham em homens vegetarianos e onívoros aparentemente saudáveis
- Case report [Editorial]: the efficacy and safety of lomitapide in a homozygous familial hypercholesterolemic child
- Cardiovascular event reduction with PCSK9 inhibition among 1578 patients with familial hypercholesterolemia: results from the SPIRE randomized trials of bococizumab
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
- Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: the International ChoLesterol management Practice Study
- Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglycerid levels in the Arabian Gulf
- Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk
- Predicting Cardiovascular Events in Familial Hypercholesterolemia
Informações sobre o DOI: 10.1016/j.jacl.2014.08.002 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
